Adam C. Salisbury

Saint Luke's Hospital, Missouri Heart Center

Papers

3

Total Citations

36

H-Index

2

About

Adam C. Salisbury is a leading interventional cardiologist whose research focuses on advancing robotic-assisted percutaneous coronary intervention (PCI), particularly for complex chronic total occlusion (CTO) cases. His pioneering work demonstrates that robotic-assisted CTO PCI is not only safe but also reduces procedural duration compared to traditional manual techniques, as shown in his highly cited 2019 study (32 citations). Salisbury’s major contributions include evaluating the safety and efficacy of robotic platforms like the CorPath 200 and GRX systems, culminating in the landmark PRECISION and PRECISION GRX studies (2025). These large-scale trials confirmed that robotic PCI minimizes occupational radiation and ergonomic hazards for cardiologists while maintaining excellent clinical outcomes. With over 30 citations for his foundational CTO work, Salisbury has established robotic assistance as a viable tool for even the most challenging coronary interventions. His research bridges the gap between innovation and clinical practice, offering interventional cardiologists a safer, more precise approach to treating complex coronary artery disease.

Research Focus

Key Achievements

2
H-Index
3
Papers
36
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Initial report of safety and procedure duration of robotic‐assisted chronic total occlusion coronary intervention
32 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Saint Luke's Hospital, Missouri Heart Center

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago